// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























4759 Abstracts

Heat Shock Protein (HSP) 70 & 47 Plasma Levels in Subjects with Diabetic Foot and Its Possible Correlation with Clinical Variables in a North Indian Tertiary Care Hospital

Mohammad Zubair - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic foot

N/A

Correlation Between Glycated Hemoglobin Levels of Type 2 Diabetetic Patients, Antioxidant Enzyme Activities and Serum Nitric Oxide

Luciene de Carvalho Cardoso Weide - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Superoxide dismutase

Accelerated Accumulation of Tissue Advanced Glycation Endproducts (AGE) in Youth with Type 1 Diabetes (T1D): Preliminary Results from a Longitudinal Study

Abdulhameed Y. Alsaheel - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Metformin Treatment of Gestational Diabetes Results in Similar Glycemic Control and Infant Outcomes but Less Maternal Weight Gain Than Insulin Treatment

Mark McLean - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

Metformin controlled release

Cognitive Dysfunction and Gestational Diabetes Mellitus

Fatma Ela Keskin - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Urine Microalbumin to Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth

Sara Klinepeter Bartz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

Cardiovascular Safety of DPP-4 Inhibition in Patients with Type 2 Diabetes Mellitus: Endothelial Progenitor Cells As an Early Marker of Long-Term Cardiovascular Risk

Wan Aizad Wan Mahmood - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

saxagliptin

Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes

Yasuhiro Ohno - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Vildagliptin

The Role of Vitamin D in Preventing Leaky GUT-Induced Endotoxemia in African American Veterans at Risk for Diabetes

Irina Ciubotaru - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Ergocalciferol

HIV/HCV Co-Infection Is Associated with Different Lipid and Hepatic Profile Comparing to Mono-Infected By HIV Infection

Catarina Castelo Branco - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Human immunodeficiency virus infection

Alkaline phosphatase

Association of Serum High-Sensitivity C - Reactive Protein to Metabolic Control and Chronic Vascular Complications in Patients with Type 2 Diabetes

Somlak Chuengsamarn - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral neuropathy

N/A

Skin Autofluorescence Ages Are Associated with Ultrasound Alterations of the Carotid in Subjects of Recent Diagnosis of Type 2 Diabetes Mellitus

Ma. Etzabel Villegas-Rodriguez - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Urine Microalbumin to Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth

Sara Klinepeter Bartz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

Differential Morning Vs. Evening Insulin and Glucagonlike Peptide-1 (GLP-1) Responses after Identical Meal in Type 2 Diabetic Subjects

Daniela Jakubowicz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Pre-Meal Consumption of Whey Protein Enhances Intact and Total Glucagonlike Peptide-1 and Insulin Postprandial Responses in Type 2 Diabetes

Daniela Jakubowicz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Prandial Insulin

Comparison of Fish or Meat Intake before and after Rice on Postprandial Glucose Excursions and Incretin Secretion in Type 2 Diabetes: Meal-Sequence As a Novel Target in Dietary Therapies for Diabetes

Daisuke Yabe - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Icosapent ethyl

Uric Acid-Induced Low Grade Inflammation Is Mediated By Parathyroid Hormone: 25-Hydroxyvitamin D Ratio in Obese Adolescents

Ramin Alemzadeh - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Parathyroid hormone

Evaluation of Coagulation Profile with Using Thromboelastography in Children and Adolescents with Type 1 Diabetes Mellitus

Cigdem Binay - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Fibrinogen (IV)

Children with Type 1 Diabetes Meet Recommendations for Physical Activity but Not Sleep Duration

Jemma Jay Angela Anderson - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Contrasting Effects of Sitagliptin and Exenatide on Plasma Concentrations of Betatrophin

Husam Ghanim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

betatrophin

Copyright © 2026. QuantiNova All rights reserved